Hasil Pencarian - Jonathan Wadsley
Anda harus masuk terlebih dahulu
- Menampilkan 1 - 7 hasil dari 7
-
1
-
2
Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic model oleh Paul Tappenden, Christopher Carroll, Jean Hamilton, Eva Kaltenthaler, Ruth Wong, Jonathan Wadsley, Laura Moss, Sabapathy Balasubramanian
Diterbitkan 2019-02-01Dapatkan teks lengkap
Artikel -
3
Identifying ways to improve diabetes management during cancer treatments (INDICATE): protocol for a qualitative interview study with patients and clinicians oleh Ian Kellar, Galina Velikova, Lisa Kidd, Frances Mair, Johanna Taylor, Daniel Swinson, Jonathan Wadsley, Laura Ashley, Mike Matthews, Saifuddin Kassim, Mollie Price
Diterbitkan 2022-02-01Dapatkan teks lengkap
Artikel -
4
Mental health burden for NHS healthcare staff during the COVID-19 pandemic: First results of a longitudinal survey oleh Sarah Danson, Fuschia Sirois, Kathryn Fradley, Jonathan Wadsley, Jaydip Ray, Rhian Bishop, Janet Horsman, Colette Mann, Loretta Chantry-Groves, Matthew Young, Richard Bentall
Diterbitkan 2023-03-01Dapatkan teks lengkap
Artikel -
5
Feasibility of delivering supervised exercise training following surgical resection and during adjuvant chemotherapy for pancreatic ductal adenocarcinoma (PRECISE): a case series oleh Malcolm Brown, Dominic O’Connor, Richard Turkington, Martin Eatock, Rebecca Vince, Claire Hulme, Roy Bowdery, Rebecca Robinson, Jonathan Wadsley, Anthony Maraveyas, Gillian Prue
Diterbitkan 2023-09-01Dapatkan teks lengkap
Artikel -
6
Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy (SEL-I-METRY): protocol... oleh Sarah R. Brown, Andrew Hall, Hannah L. Buckley, Louise Flanagan, David Gonzalez de Castro, Kate Farnell, Laura Moss, Rebecca Gregory, Kate Newbold, Yong Du, Glenn Flux, Jonathan Wadsley
Diterbitkan 2019-06-01Dapatkan teks lengkap
Artikel -
7
NET-02: a randomised, non-comparative, phase II trial of nal-IRI/5-FU or docetaxel as second-line therapy in patients with progressive poorly differentiated extra-pulmonary neuroen... oleh Mairéad G. McNamara, Jayne Swain, Zoe Craig, Rohini Sharma, Olusola Faluyi, Jonathan Wadsley, Carys Morgan, Lucy R. Wall, Ian Chau, Nick Reed, Debashis Sarker, Jane Margetts, Daniel Krell, Judith Cave, Sharmila Sothi, Alan Anthoney, Christopher Bell, Alkesh Patel, Jamie B. Oughton, David A. Cairns, Wasat Mansoor, Angela Lamarca, Richard A. Hubner, Juan W. Valle
Diterbitkan 2023-06-01Dapatkan teks lengkap
Artikel